1. Metformin and survival: Is there benefit in a cohort limited to diabetic women with endometrial, breast, or ovarian cancer?
    Lara S. Lemon et al, 2022, Gynecologic Oncology CrossRef
  2. CDCA3 exhibits a role in promoting the progression of ovarian cancer
    Shan Gong et al, 2022, Tissue and Cell CrossRef
  3. Anti-Cancer Activity of Cannabis sativa Phytocannabinoids: Molecular Mechanisms and Potential in the Fight against Ovarian Cancer and Stem Cells
    Hinanit Koltai et al, 2022, Cancers CrossRef
  4. Association Between Adrenal-Restrictive HSD3B1 Inheritance and Hormone-Independent Subtypes of Endometrial and Breast Cancer
    Jeffrey M McManus et al, 2022 CrossRef
  5. Hormonal Therapy in Pretreated Patients With Recurrent Ovary Granulosa Cell Tumor
    Izzet Dogan et al, 2022, Journal of Pharmacy Practice CrossRef
  6. Molecular Management of High-Grade Serous Ovarian Carcinoma
    Paula Punzón-Jiménez et al, 2022, IJMS CrossRef
  7. Comparative Analysis of Transcriptomic Changes including mRNA and microRNA Expression Induced by the Xenoestrogens Zearalenone and Bisphenol A in Human Ovarian Cells
    Éva Márton et al, 2023, Toxins CrossRef
  8. Coicis Semen for the treatment of malignant tumors of the female reproductive system: A review of traditional Chinese medicinal uses, phytochemistry, pharmacokinetics, and pharmacodynamics
    Xue Pan et al, 2023, Front. Pharmacol. CrossRef
  9. The Role of Natural and Semi-Synthetic Compounds in Ovarian Cancer: Updates on Mechanisms of Action, Current Trends and Perspectives
    Md. Rezaul Islam et al, 2023, Molecules CrossRef
  10. Prognostic value of β-Arrestins in combination with glucocorticoid receptor in epithelial ovarian cancer
    Ji-Won Ryu et al, 2023, Front. Oncol. CrossRef
  11. Study of the radioprotective properties of fumaric acid and 3-hydroxypyridine fumarate under the action of ionizing radiation on human cells
    P. S. Kuptsova et al, 2023, Radiac. gig. (2008) CrossRef
  12. Cancer-biomarkers associated with sex hormone receptors and recent therapeutic advancements: a comprehensive review
    Suvitha Anbarasu et al, 2023, Med Oncol CrossRef
  13. Current Understanding on Why Ovarian Cancer Is Resistant to Immune Checkpoint Inhibitors
    Anna Pawłowska et al, 2023, IJMS CrossRef
  14. Role of chemotherapeutic drugs in immunomodulation of cancer
    Oishi Mukherjee et al, 2023, Current Research in Immunology CrossRef
  15. Gynecological Cancers and Microbiota Dynamics: Insights into Pathogenesis and Therapy
    Giovanna Cocomazzi et al, 2024, IJMS CrossRef
  16. Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors
    Shahil Alam et al, 2024, Cancer Drug Resist CrossRef
  17. Evaluation of consumer self-selection of a proposed over-the-counter, progestin-only daily oral contraceptive
    Stephanie Sober et al, 2024, Contraception CrossRef
  18. Biomarkers in Ovarian Cancer: Towards Personalized Medicine
    Carlos López-Portugués et al, 2024, Proteomes CrossRef
  19. From desert flora to cancer therapy: systematic exploration of multi-pathway mechanisms using network pharmacology and molecular modeling approaches
    Adel Alblihy, 2024, Front. Pharmacol. CrossRef
  20. Novel frontiers in urogenital cancers: from molecular bases to preclinical models to tailor personalized treatments in ovarian and prostate cancer patients
    Giada De Lazzari et al, 2024, J Exp Clin Cancer Res CrossRef
  21. null
    Michael Li et al, 2024 CrossRef
  22. Antitumor progestins activity: Cytostatic effect and immune response
    T. Pavlik et al, 2024, Steroids CrossRef
  23. The Megacomplex protects ER-alpha from degradation by Fulvestrant in epithelial ovarian cancer
    Sushil Kumar Jaiswal et al, 2024, Cancer Letters CrossRef
  24. Estradiol and Estrogen-like Alternative Therapies in Use: The Importance of the Selective and Non-Classical Actions
    Szidónia Farkas et al, 2022, Biomedicines CrossRef
  25. A 10-year retrospective study of the risks and peculiarities in pediatric patients with (para)gonadal tumors and cysts
    Usiwoma Okeroghene Ataikiru et al, 2024, Rom J Morphol Embryol CrossRef
  26. Extracellular Vesicles in Ovarian Cancer: From Chemoresistance Mediators to Therapeutic Vectors
    Barathan Muttiah et al, 2024, Biomedicines CrossRef